- |||||||||| SPX-101 / SparX
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date, Metastases: Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors (clinicaltrials.gov) - Oct 31, 2024 P1, N=0, Withdrawn, N=27 --> 0 | Trial completion date: Aug 2023 --> Aug 2024 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2023 --> Apr 2024
|